Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: The Proceedings of the 3rd International Conference on Food Factors (ICoFF 03)
Article type: Research Article
Authors: Ishikado, Atsushi | Imanaka, Hiromichi | Kotani, Mayumi | Fujita, Akihito | Mitsuishi, Yoko | Kanemitsu, Tomoyuki | Tamura, Yoshiko | Makino, Taketoshi
Affiliations: R&D Center, Sunstar Inc. 3-1, Asahi-Machi, Takatsuki, Osaka 569-1195, Japan | Immunogenetic Laboratory, Louis Pasteur Center for Medical Research, Japan | R&D Division, Q.P. Corporation, Japan
Note: [] Corresponding author. Tel.: +81 72 682 5570; Fax: +81 72 681 8202; E-mail: atsushi.ishikado@unisunstar.com
Abstract: Interferon-alpha (IFN-α) producibility has been widely accepted as one of the important markers to evaluate the immune status [1,2]. In this study, preliminary clinical tests were carried out to confirm the immunomodulatory activity of liposomal lactoferrin including IFN-α producibility and NK activity. In a primary open trial, the liposomal lactoferrin was administered to five healthy males for one week and various immunological indices were evaluated. Furthermore, ten healthy males were administered 319 mg per day of liposomal or non-liposomal lactoferrin for four weeks, and immune status was monitored at 0, 1 and 4 weeks after the intake as well as three weeks after stopping it. In this double-blinded comparative study, the IFN-α producibility was significantly increased only in the liposomal lactoferrin group during administration and decreased 3 weeks after stopping it, while the IFN-α producibility was unchanged in the non-liposomal lactoferrin group. Although the biological mechanism of IFN-α producibility enforced by liposomal lactoferrin has not been wholly understood, it is suggested to be a novel active constituent having preventive and therapeutic effects on inflammatory diseases, cancer and infectious diseases such as chronic hepatitis C.
Keywords: lactoferrin, liposome, multi-lamellar vehicle, immunological indices, interferon-alpha producibility, NK activity, hepatitis C
Journal: BioFactors, vol. 21, no. 1-4, pp. 69-72, 2004
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl